In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

BACKGROUND: Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) have shown significant cardiovascular benefits in patients with and without type 2 diabetes mellitus (T2DM). They have also gained interest for their potential anti-arrhythmic role and their ability to reduce the occurrence of atrial f...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesaro, Arturo, Gragnano, Felice, Paolisso, Pasquale, Bergamaschi, Luca, Gallinoro, Emanuele, Sardu, Celestino, Mileva, Niya, Foà, Alberto, Armillotta, Matteo, Sansonetti, Angelo, Amicone, Sara, Impellizzeri, Andrea, Esposito, Giuseppe, Morici, Nuccia, Oreglia, Jacopo Andrea, Casella, Gianni, Mauro, Ciro, Vassilev, Dobrin, Galie, Nazzareno, Santulli, Gaetano, Pizzi, Carmine, Barbato, Emanuele, Calabrò, Paolo, Marfella, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551177/
https://www.ncbi.nlm.nih.gov/pubmed/36237914
http://dx.doi.org/10.3389/fcvm.2022.1012220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551177/
https://www.ncbi.nlm.nih.gov/pubmed/36237914
http://dx.doi.org/10.3389/fcvm.2022.1012220

Ejemplares similares